Divis Laboratories Ltd vs Shree Ganesh Remedies Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Divis Laboratories Ltd is ₹ 6653 as of 05 May 15:30 . The P/E Ratio of Divis Laboratories Ltd changed from 48.6 on March 2021 to 69.8 on March 2025 . This represents a CAGR of 7.51% over 5 yearsThe P/E Ratio of Shree Ganesh Remedies Ltd changed from 30.5 on March 2024 to 39.6 on March 2025 . This represents a CAGR of 13.95% over 2 years The Market Cap of Divis Laboratories Ltd changed from ₹ 96366 crore on March 2021 to ₹ 153257 crore on March 2025 . This represents a CAGR of 9.72% over 5 yearsThe Market Cap of Shree Ganesh Remedies Ltd changed from ₹ 801.21 crore on March 2024 to ₹ 913.01 crore on March 2025 . This represents a CAGR of 6.75% over 2 years The revenue of Divis Laboratories Ltd for the Dec '25 is ₹ 2692 crore as compare to the Sep '25 revenue of ₹ 2860 crore. This represent the decline of -5.87% The revenue of Shree Ganesh Remedies Ltd for the Dec '25 is ₹ 21.76 crore as compare to the Sep '25 revenue of ₹ 31 crore. This represent the decline of -29.81% The ebitda of Divis Laboratories Ltd for the Dec '25 is ₹ 904 crore as compare to the Sep '25 ebitda of ₹ 1033 crore. This represent the decline of -12.49% The ebitda of Shree Ganesh Remedies Ltd for the Dec '25 is ₹ 7.39 crore as compare to the Sep '25 ebitda of ₹ 10.31 crore. This represent the decline of -28.32% The net profit of Divis Laboratories Ltd changed from ₹ 430 crore to ₹ 583 crore over 7 quarters. This represents a CAGR of 19.00% The net profit of Shree Ganesh Remedies Ltd changed from ₹ 4.65 crore to ₹ 3.09 crore over 7 quarters. This represents a CAGR of -20.83% The Dividend Payout of Divis Laboratories Ltd changed from 27.16 % on March 2021 to 35.99 % on March 2025 . This represents a CAGR of 5.79% over 5 yearsThe Dividend Payout of Shree Ganesh Remedies Ltd changed from 17.97 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 years .

About Divis Laboratories Ltd

Divi's Laboratories Limited is one of the leading pharmaceutical companies in the world, manufacturing Active Pharmaceutical Ingredients (APIs), Intermediates and Nutraceuticals.
The Company is one of the world's largest API companies, with two manufacturing units and a market presence across 100 countries.
It is engaged in the manufacture of Active Pharmaceutical ingredients (API's), Intermediates and Nutraceutical ingredients with predominance in exports.
In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management.
It is among the largest pharmaceutical companies in India with a portfolio of approx.

About Shree Ganesh Remedies Ltd

Shree Ganesh Remedies Limited was originally incorporated as a Private Limited Company with the name 'Shree Ganesh Remedies Private Limited' at Ahmedabad, Gujarat on April 27, 1995.
Subsequently the Company was converted into a Public Limited and the name of the Company was changed to 'Shree Ganesh Remedies Limited' on July 28, 2017.
The Company, a part of Ganesh Group has carved for itself a niche in the industry of manufacturing pharmaceutical intermediates and fine chemicals. Shree Ganesh Remedies is a ISO 9001:2015, ISO 14001:2015 BS and OHSAS 18001:2007 certified Company and is engaged in manufacturing and dispatch of drug intermediates and chemicals like amine hydrochloride and specialty fine chemicals for pharmaceutical industry.
The Company manufactures products relating to antipsychotic, antiseptic, deprotonation reactions, hyperlipidemia, alzheimers and anti-viral.

FAQs for the comparison of Divis Laboratories Ltd and Shree Ganesh Remedies Ltd

Which company has a larger market capitalization, Divis Laboratories Ltd or Shree Ganesh Remedies Ltd?

Market cap of Divis Laboratories Ltd is 176,617 Cr while Market cap of Shree Ganesh Remedies Ltd is 621 Cr

What are the key factors driving the stock performance of Divis Laboratories Ltd and Shree Ganesh Remedies Ltd?

The stock performance of Divis Laboratories Ltd and Shree Ganesh Remedies Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Divis Laboratories Ltd and Shree Ganesh Remedies Ltd?

As of May 5, 2026, the Divis Laboratories Ltd stock price is INR ₹6653.05. On the other hand, Shree Ganesh Remedies Ltd stock price is INR ₹484.05.

How do dividend payouts of Divis Laboratories Ltd and Shree Ganesh Remedies Ltd compare?

To compare the dividend payouts of Divis Laboratories Ltd and Shree Ganesh Remedies Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.